Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Incentive Stock Option (Right to Buy) | 210K | $2.38M | $11.31 | Apr 14, 2025 | Direct |
LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Common Stock | 215K | $1.23M | $5.74 | Apr 14, 2025 | Direct |
LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Performance-Based Restricted Stock Units | 0 | $0 | $5.74 | Apr 14, 2025 | Direct |
LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | No Security beneficially owned | 0 | Apr 14, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | Apr 14, 2025 | 4 | $0 | 4 | Apr 16, 2025 | Chief Legal & Administration |
LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | Apr 14, 2025 | 0 | $0 | 3 | Apr 16, 2025 | Chief Legal & Administration |